Marfan Genetic Counselling — EECC MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Marfan syndrome is autosomal dominant with 50% transmission risk to each offspring; prenatal genetic testing and pre-implantation genetic diagnosis are available for known FBN1 mutations
Marfan syndrome is an autosomal dominant connective tissue disorder caused by mutations in the FBN1 gene (fibrillin-1). Each child of an affected parent has a 50% chance of inheriting the condition. However, approximately 25% of cases are de novo mutations. Genetic counselling should cover: (1) 50% transmission risk; (2) variable expressivity (even within the same family, clinical severity varies); (3) prenatal testing options (chorionic villus sampling or amniocentesis for known FBN1 mutations); (4) pre-implantation genetic diagnosis (PGD) available with IVF for known mutations; (5) pregnancy-related aortic risk for the affected parent (aortic dissection risk increases in pregnancy, particularly if root >40 mm). The 2025 ESC CVD in Pregnancy Guidelines classify Marfan with aorta >45 mm as mWHO IV.
Reference: ESC (2025): CVD in Pregnancy; ESC (2024): Aortic Disease Guidelines